5:45 PM
 | 
Jun 24, 2013
 |  BC Extra  |  Company News

SCOTUS declines Momenta case

The U.S. Supreme Court declined to hear an appeal from Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), rebuffing the company's attempt to stop sales of a competing generic version of anticoagulant enoxaparin. Momenta's patent infringement suit against Amphastar...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >